Alcoholic cirrhosis and vin\1 cirrhosis are associated with alteratio!!~ ~: immune system function and cytokine production. OUf aim was to investigate whether serum concentrations of soluble receptors for interleukin-2 (sIL-2 R) and tumor necrosis factor (55kD-type, sTNFR-55), and serum neopterin can be used as markers to establish differences in etiology and sevnity in liver cirrhosis and to d(>~.:rmine whether they correlate with laboratory and clinical parameters. Thirty three patients with alcoholic and 15 with viral cirrh:lsis (classified according to the Child-Pugh score of severity of liver disease) and 43 healthy controls were studied. Serum concentrations of sIL2-R, sTNFR-55 and neopterin were significantly raiset\ in patients. No significant differe;1ices between alcoholic and viral cirrhosis were found. The concentrations of sIL-2 Rand sTNFR-55 were significantly higher in patients with more severe disease. There existed correlations b<!tween sIL-2R and sTNFR-55 (rs = 0 .50, P < 0.001) and between both soluble receptors and the Child-Pugh score (sTNF-R55: rs = 0.70, p < 0.001; sIL-2R: rs = 0.33 , p < 0.05) and serum albumin. The results are likely to reflect that the monocyte-macrophage and T-cell functions are stimulated in patients with liver cirrhosis independently of the etiology of the d~s c;;;:;c, ~::~ !~:!! ~e:-~i~~e::~ ;:c!: vation of the immune system occurs in cirrhosis even at the end stage of the disease. Chronic immune activation might have deletereous consequences on the evolution of cirrhosis.
Introduction
Alcoholic cirrhosis and cirrhosis of viral origin are associated with disturbances of the inunune system (1) . There exists increasing evidence of activation of the monocytes/macrophages system in these diseases, as shown by elevated circulating levels of interleukin-1 (IL-l), interleukin-6 (IL-6), tumor necrosis factor (TNF) and neopterin (2) (3) (4) . It has been suggested an involvement of the inunune system in the pathogenesis of the disease that may contribute, in addition, to the development of clinical complications. TNF is produced mainly by activated macrophages and monocytes (5, 6) , and exerts its biological functions by binding to specific cell surface receptors (7) . Soluble forms of TNF receptors (sTNF-Rs) are shed from cell surface and can modify the bioactivity of TNF (8) . Neopterin is a pyrazino-pyrimidine compound which is produced mainly by activated monocyteslmacrophages and dendritic cells under stimulation by endogenous gamma-interferon derived from activated T cells in humans (9) . A positive correlation between serum concentrations of neopterin and the activation of the cellular inunune system has been shown in vivo and in vitro (10) . Soluble receptors for Interleukin-2 (sIL-2R) are released mainly from activated T cells and the serum concentrations of sIL-2R reflect early lymphocyte activation (11, 12) . Increased serum concentrations of the three soluble immune markers have been found in a wide variety of diseases, including autoimmune disorders, malignancies, viral infections and liver diseases (8, 10, (12) (13) (14) (15) (16) (17) . From this background the question emerges if raised concentrations of these soluble markers of immune activation in liver cirrhosis of viral origin are related to viral infection or are due to hepatic damage present in cirrhotic patients. The aim of this study was to examine whether serum levels of sIL-2R, sTNF-R and neopterin can be used as markers to establish differences in etiology and severity in liver cirrhosis and to determine if they correlate with laboratory and clinical parameters.
Patients and Methods
Forty eight male patients (mean age of 57.5 years) with liver cirrhosis were included in this study. The diagnosis of liver cirrhosis was based on liver biopsy in 37 patients, in the remaining 11 patients on the following clinical and laboratory data and exploratory findings: signs of chronic liver disease, reduced prothrombine activity, hypoalbuminemia, abnormal 99mTc-liver-spleen scan, esophageal varices at endoscopy and collateral circulation at echography. Patients with malignancy, endocrine, cardiac or lung disease and patients with other diseases that might have affected their immune status were excluded. Thirty three patients were diagnosed as alcoholic cirrhosis on the basis of liver histology and/or a history of daily alcohol comsumption of more than 80 g/day for more than 15 years. Fifteen patients were diagnosed of viral cirrhosis on the basis of no history of daily alcohol comsumption (less than 3 drinks a week) and positive serological markers for viral hepatitis (4 HBs-Ag-and II HCV-Ab positive). The 48 cirrhotic patients were classified into three groups according to the Child-Pugh score of severity of liver disease (18): grade A: 16 patients, mean age 54 years (range 40 -66), grade B: 17 patients, mean age 64 (range 40 -74), grade C:15 patients, mean age 63 (range 50 -70). At the time of recruitment, no patient had alcohol consumption during at least one month before enrollment in the study. All patients received complete information and gave their informed consent to participate in the study. The control group consisted of 43 sex and age-matched healthy blood donors who were identified as nondrinkers. 55kD-type sTNFR (sTNFR-55) and sIL-2R were measured by enzyme-linked immunosorbent assay (T Cell Sciences, Cambridge, MA, USA), and serum neopterin by ELISA (BRAHMS-Diagnostica, Berlin, Germany). In addition, cirrhotic patiens were analysed according to the Child-Pugh score of severity of liver disease.
Comparisons of sTNFR-55 concentrations among Child A, B or C group and controls showed statistically significant differences (Table 2) . Differences for sIL-2R concentrations were statistically significant only between grade A and grade C patients (Table 2 ). No differences in neopterin concentrations were found among the Child groups. When examining the 47 cirrhotic patients as a single group, there existed significant correlations between serum sTNFR-55 and serum sIL-2R (rs = 0.50;P < 0.001), and between serum albumin and sTNFR-55 (rs = -0.71; P < 0.001) and sIL-2R (rs = -0.33; P < 0.05).
Correlations were also significant between the ChildPugh score and serum sTNFR-55 (rs = 0.70, P < 0.001; Fig. 1 ) as well as serum sIL-2R (rs = 0.33, P < 0.05; Fig.2 ). 'P < 0.05, bp < 0.01 , cp < 0.001 (all versus controls) dp < 0.05, op < 0.001, t'p < 0.001 (group Band C versus group A)
Discussion
In the present study, significantly elevated serum concentrations of sTNFR-55, neopterin and sIL-2R were found in both alcoholic and viral cirrhosis. No differences between concentrations of these immune markers were observed in the two etiologic groups. The patients with more severe disease had the higher concentrations of serum immune markers. There are few reports on the role of sTNFR-55 as an etiologic marker in liver disease. Receptors for TNF have been reported to be increased in hepatocytes, bile duct epithelium and infiltrating monocytes in chronic hepatitis of various causes (19) . Elevated Child-Pugh score We have found increased serum neopterin concentrations in patients with liver disease and also no differences have been observed between alcoholic cirrhosis and viral cirrhosis. Two previous studies have suggested that measurement of urinary neopterin could be a reliable method for differentiating between viral and alcoholic liver diseases, and that patients with viral hepatitis had higher neopterin concentrations than patients with alcoholic liver disease (22, 23). Nevertheless, another study (4) has shown no differences between serum neopterin concentrations in these two etiologic groups of cirrhotic patients, which agrees with our findings . From the data it seems that urinary neopterin measurement is more sensitive to distinguish etiologic differences of liver cirrhosis, or different patients selection could be important. It may also be the reason why we could find only a trend to higher neopterin concentrations in patients with higher Child-Pugh score but no significant differences as was found in an earlier investigation (13). Also no correlation existed between serum neopterin and other biochemical parameters. Further studies will be needed to clarify this issue. These data suggest that, although serum neopterin is elevated in liver cirrhosis, these raised concentrations do 110t help to predict either severity or etiology of the disease. We have found increased sIL-2R in both types of cirrhosis , without significant differences between the two etiologic groups. Some studies showed elevated serum concentrations of sIL-2R in chronic hepatitis, that were related to histologic damage (16, 24) and in alcoholic liver disease (17). Our study shows no difference between viral or alcoholic origin and the highest serum sIL-2R concentrations were found in patients with advanced liver disease. Taking in account these data and the positive correlation of sIL-2R with biochemical and clinical parameters, it is likely that hepatocellular failure and porto-systemic shunting could be responsible for the high serum sIL-2R concentrations in these patients, similar to the increase of sTNFR-55. The positive correlation observed in our study between sTNFR-55 with sIL-2R and between both soluble factors with Child score may reflect the same influence of liver failure or porto-systemic shunting on the immune system by a defective hepatic clearance of these molecules and/or by the chronic immune stimulation provided by intestinal products that enter the systemic circulation across porto-systemic shunts avoiding the hepatic filter and Kupffer cells' function. Independent from the etiology of disease, our data are likely to reflect the stimulation of monocytemacrophage and T-cell functions in patients with liver cirrhosis. From the data it appears that persistent activation of the immune system occurs in cirrhosis even at the advanced evolutive stages. As shown in other diseases (25), the persistent immune activalion might have deleterious consequences on the evo lution of cirrhosis. Child-Pugh score 
